The U.S. Supreme Court will consider the legality of Purdue Pharma’s bankruptcy plan this December, which the federal government argues illegally releases the company-owning Sackler family from liability in future opioid litigation.

The justices agreed to hear the case in an unsigned order Thursday afternoon.